The Serum Institute of India will produce trial doses of Oxford's experimental Ebola vaccine, supported by $8.6 million in CEPI funding to combat Bundibugyo ebolavirus outbreaks.
CEPI has announced funding of up to $8.6M for the project
Jun 02, 2026
01:16 pm
What's the storyThe Serum Institute of India (SII) will manufacture clinical trial doses of an experimental Ebola vaccine developed by the University of Oxford.
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced funding of up to $8.6 million to fast-track efforts against the quickly spreading Bundibugyo ebolavirus outbreak in Africa.
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
Moderna and other groups get $60m to develop Ebola vaccine
Scientists target human trials for new Ebola vaccine 'within months'
Race for Ebola vaccine gets $60m boost - Businessday NG
Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post
Health body fast-tracks three Ebola vaccines as virus continues spread
Experts evaluate promising Ebola treatments, including vax candidate from Oxford/Serum Institute
Ebola: $62 million pledge to speed up vaccine development
Moderna and other groups get $60 million to develop Ebola vaccine - The Korea Times
Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is…
Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.
BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the…
This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.
Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of…
Production of an experimental Ebola vaccine from the developers of a Covid-19 shot is expected to begin soon, with animal…
